Home Awards and Honors Media Placements Bridging the Cultural Gap Links Contact

News Archive

 

FSD Pharma’s “Huge” Plans on Milestone IPO Day

January 23rd, 2020

FSD Pharma CEO, Dr. Raza Bokhari, with Olivia Voznenko on Modern Wall Street, discusses how the company looks to tackle the opioid epidemic by producing opioid sparing medications which can treat chronic pain.

Click here to watch the video.

Email to a friend


FSD Pharma Inc. Rings the Opening Bell | NASDAQ

January 22nd, 2020

Dr Raza Bokhari, FSD Pharma CEO, rings the Opening Bell at the NASDAQ Stock exchange.

Click here to watch the video.

Email to a friend


Cannabis Company FSD Pharma Celebrates First Weeks on NASDAQ

January 22, 2020

FSD Pharma CEO, Dr. Raza Bokhari, live on the Cheddar Network with Chloe Aiello, discusses the company’s recent listing on NASDAQ.

Click here to watch the video.

Email to a friend


Dr. Raza Bokhari Discusses FSD Pharma

January 22nd, 2020

FSD Pharma CEO, Dr Raza Bokhari, live on TD Ameritrade network with Nicole Petallides, states today we are a specialty pharmaceutical R&D company.

Click here to watch the video.

Email to a friend


FSD Pharma rings the Nasdaq opening bell in 'exciting and momentous moment'

January 22nd, 2020

FSD Pharma CEO, Dr Raza Bokhari, live on Proactive Investors with Christine Corrado in Times Square, says it’s an exciting and momentous moment, they are indeed humbled, but our work has just begun.

Click here to watch the video.

Email to a friend


FSD Pharma Begins Trading at Nasdaq

January 13th, 2020

Dr Raza Bokhari, FSD Pharma CEO, with Debra Borchardt on Green Market Report, says the way to unlock the real potential of the cannabinoid molecule is through clinical trials to produce FDA approved prescription drugs.

Click here to watch the video.

Email to a friend


FSD Pharma Takes Major Step Forward Listing on Nasdaq Under the Symbol “HUGE”

January 9th, 2020

FSD Pharma CEO, Dr Raza Bokhari, with Steve Darling from Proactive Investors, says the listing on NASDAQ places FSD in a select group of 12 cannabis related companies that are Canadian domiciled and dual listed on a major US Stock exchange.

Click here to watch the video.

Email to a friend


FSD Pharma aims to initiate a Phase 2 coronavirus treatment trial by end 2020 as it files IND

Sept 10, 2020

FSD Pharma CEO, Dr. Raza Bokhari speaks about filing with the FDA an IND Application to initiate phase 2 clinical trial to treat hospitalized COVID-19 patients. 

Click here to watch the full video

FSD Pharma says $10M in new capital is 'gratifying' as the firm makes progress in coronavirus trial

August 10, 2020

FSD Pharma CEO, Dr. Raza Bokhari, on Proactive Investors spoke about completing US$10 million registered offering and provides progress  update on submitting IND Application to the FDA to use FSD201 to treat COVID-19 patients.

Click here to watch the full video

FSD Pharma – FDA Approval to Submit I.N.D. Application for Compound to Treat Covid-19 Patients

July 2, 2020

Dr Raza Bokhari, FSD Pharma CEO, talks about developing its ultra micro PEA Compound to treat COVID-19....

Click here to watch the video.

View Archive
Home | Awards and Honors | Media Placements | Bridging the Cultural Gap | Links | Contact © 2007 Dr. Raza Bokhari · All rights reserved.